Prelude Capital Management’s Pacira BioSciences PCRX Stock Holding History

Prelude Capital Management’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.15M	Buy	50,735 +6,740	+15%	+$150K	0.09%	274
2025 Q4	$1.14M	Buy	43,995 +7,460	+20%	+$177K	0.08%	268
2025 Q3	$942K	Buy	36,535 +12,300	+51%	+$302K	0.07%	317
2025 Q2	$579K	Sell	24,235 -104	-0.4%	-$2.62K	0.06%	395
2025 Q1	$605K	Buy	24,339 +4,804	+25%	+$115K	0.06%	448
2024 Q4	$368K	Sell	19,535 -2,400	-11%	-$42.1K	0.03%	714
2024 Q3	$330K	Buy	21,935 +2,518	+13%	+$43K	0.03%	814
2024 Q2	$556K	Buy	19,417 +4,892	+34%	+$139K	0.05%	498
2024 Q1	$424K	Buy	14,525 +7,841	+117%	+$241K	0.03%	705
2023 Q4	$226K	Buy	+6,684	New	+$196K	0.02%	887
2023 Q3	–	Sell	-6,990	Closed	-$280K	–	1330
2023 Q2	$280K	Buy	+6,990	New	+$289K	0.02%	680
2022 Q3	–	Sell	-9,837	Closed	-$573K	–	1877
2022 Q2	$573K	Buy	9,837 +2,491	+34%	+$163K	0.03%	744
2022 Q1	$561K	Sell	7,346 -4,481	-38%	-$299K	0.03%	813
2021 Q4	$712K	Buy	+11,827	New	+$652K	0.04%	807
2020 Q3	–	Sell	-15,447	Closed	-$811K	–	2362
2020 Q2	$811K	Buy	15,447 +3,058	+25%	+$128K	0.13%	357
2020 Q1	$415K	Buy	12,389 +6,875	+125%	+$286K	0.09%	341
2019 Q4	$250K	Sell	5,514 -3,160	-36%	-$134K	0.03%	785
2019 Q3	$330K	Sell	8,674 -8,653	-50%	-$345K	0.04%	635
2019 Q2	$754K	Buy	17,327 +17,121	+8,311%	+$727K	0.07%	414
2019 Q1	$8K	Buy	+206	New	+$8.04K	﹤0.01%	1537
2017 Q4	–	Hold	0	–	–	–	1655
2017 Q3	–	Hold	0	–	–	–	1872
2017 Q2	–	Hold	0	–	–	–	1814
2017 Q1	–	Hold	0	–	–	–	1733
2016 Q4	–	Hold	0	–	–	–	1743
2016 Q3	–	Sell	-1,144	Closed	-$44.8K	–	1774
2016 Q2	$39K	Sell	1,144 -950	-45%	-$46.7K	0.01%	1092
2016 Q1	$111K	Sell	2,094 -1,239	-37%	-$72.5K	0.02%	726
2015 Q4	$256K	Buy	+3,333	New	+$189K	0.04%	461
2015 Q1	–	Sell	-300	Closed	-$27K	–	2120
2014 Q4	$27K	Sell	300 -950	-76%	-$89.9K	﹤0.01%	1655
2014 Q3	$121K	Buy	1,250 +1,150	+1,150%	+$112K	0.02%	1002
2014 Q2	$9K	Buy	+100	New	+$7.62K	﹤0.01%	1823